Skip to content
  • Wednesday, 14 October 2026
  • 12:46 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • FDA Approves Zanvastro as the First Disease-Modifying Treatment for Rare Alexander Disease
Neuroscience & Brain Research

FDA Approves Zanvastro as the First Disease-Modifying Treatment for Rare Alexander Disease

Rifan Muazin Oct 14, 2026 0

The U.S. Food and Drug Administration (FDA) has officially granted approval to Zanvastro, marking a watershed moment in medical history…

Read More
Innovative Quantum Spin Polarization and Optimized Fuel Ratios Offer Breakthrough in Tritium Efficiency for Future Fusion Power PlantsAustrian Physicists Bridge Quantum Computing and Electron Microscopy to Revolutionize Atomic-Scale ImagingRevolutionizing Local AI: Fine-Tuning Language Models on Apple Silicon with MLXTWiV 1289: Building a better hepatitis B trap
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.Navigating the 2026 AI Landscape: Ten Essential Hugging Face Models for Machine Learning PractitionersScience News: A Century of Commitment to Scientific Literacy and Public EngagementPfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
Lana Keisha Oct 14, 2026
Data Science & Bioinformatics
Navigating the 2026 AI Landscape: Ten Essential Hugging Face Models for Machine Learning Practitioners
Evan Lee Salim Oct 14, 2026
Environmental & Analytical Chemistry
Science News: A Century of Commitment to Scientific Literacy and Public Engagement
Abdurrohim Arsyad Oct 14, 2026
Pharmaceutical R&D
Pfizer and Enodia Therapeutics Ink Multi-Million-Dollar Agreement to Advance Novel Sec61 Inhibitors in Major R&D Partnership
Teuku Ryan Oct 14, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ